125 related articles for article (PubMed ID: 15834542)
1. [Peace-study. Coronary heart disease: additive therapy with ACE-inhibitors?].
Böhm M
Internist (Berl); 2005 May; 46(5):592-4. PubMed ID: 15834542
[No Abstract] [Full Text] [Related]
2. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
Braunwald E; Domanski MJ; Fowler SE; Geller NL; Gersh BJ; Hsia J; Pfeffer MA; Rice MM; Rosenberg YD; Rouleau JL;
N Engl J Med; 2004 Nov; 351(20):2058-68. PubMed ID: 15531767
[TBL] [Abstract][Full Text] [Related]
3. The PEACE study: limiting the role of angiotensin-converting enzyme inhibitors in stable coronary artery disease.
Lee RT
Curr Atheroscler Rep; 2005 May; 7(3):211-2. PubMed ID: 15811255
[No Abstract] [Full Text] [Related]
4. Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?
Gupta M; Lonn EM; Verma S
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):124-5. PubMed ID: 16265450
[No Abstract] [Full Text] [Related]
5. ACE inhibitors in patients with vascular disease: should the PEACE trial change medical practice?
Carey RM
Curr Hypertens Rep; 2005 Apr; 7(2):119-20. PubMed ID: 15748535
[No Abstract] [Full Text] [Related]
6. ACE inhibition in secondary prevention: are the results controversial?
Friedrich EB; Teo KK; Böhm M
Clin Res Cardiol; 2006 Feb; 95(2):61-7. PubMed ID: 16598512
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitors for patients with vascular disease without left ventricular dysfunction--may they rest in PEACE?
Pitt B
N Engl J Med; 2004 Nov; 351(20):2115-7. PubMed ID: 15531768
[No Abstract] [Full Text] [Related]
8. ACE inhibition in stable coronary artery disease.
Myers MG
N Engl J Med; 2005 Mar; 352(9):937-9; author reply 937-9. PubMed ID: 15751128
[No Abstract] [Full Text] [Related]
9. ACE inhibitors: the impact of the EUROPA study on CAD.
Cardiovasc J S Afr; 2003; 14(4):211-2. PubMed ID: 14619870
[No Abstract] [Full Text] [Related]
10. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
12. Using ACE inhibitors appropriately.
Bicket DP
Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
[TBL] [Abstract][Full Text] [Related]
13. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibition in stable coronary artery disease.
McCullough C
N Engl J Med; 2005 Mar; 352(9):937-9; author reply 937-9. PubMed ID: 15751129
[No Abstract] [Full Text] [Related]
15. The landscape after PEACE: do all ACE inhibitors act in an identical way?
Grajek S
Curr Med Res Opin; 2006 Feb; 22(2):265-74. PubMed ID: 16466598
[TBL] [Abstract][Full Text] [Related]
16. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
17. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
18. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA).
Fox KM; Henderson JR; Bertrand ME; Ferrari R; Remme WJ; Simoons ML
Eur Heart J; 1998 Sep; 19 Suppl J():J52-5. PubMed ID: 9796841
[TBL] [Abstract][Full Text] [Related]
19. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]